Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

NCT02335918

Conditions
Adenocarcinoma, Astrocytoma, Carcinoma, +37 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • The Stanford Center for Clinical and Translational Education and Research Palo Alto, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Medical Center Aurora, Colorado, United States
View all 19 locations
View Trial Details
Completed

A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

NCT01975701

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Novartis Investigative Site Los Angeles, California, United States
  • University of California San Francisco Dept of Onc. San Francisco, California, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Completed

Retrospective Analysis of Dabrafenib +/- Trametinib Compassionate Use Experience in Spain

NCT02439411

Conditions
Malignant Melanoma Stage IIIc, Malignant Melanoma Stage IV, Melanoma, +11 more
Locations
  • Complejo Hospitalario Torrecárdenas Almería, Spain
  • Hospital Universitario Son Espases Palma de Mallorca, Balearic Islands, Spain
  • Instituto Catalán de Oncología Badalona/Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
  • Instituto Catalán de Oncología L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
View all 29 locations
View Trial Details
Completed

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

NCT01392209

Conditions
Anaplastic Astrocytoma (AA), Anaplastic Mixed Gliomas, Anaplastic Oligo-astrocytoma (AOA), +22 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details

Related conditions